HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $252,408 | -60.6% | 2,218 | -72.4% | 0.05% | -62.4% |
| Q2 2022 | $640,000 | -24.3% | 8,030 | 0.0% | 0.14% | -25.4% |
| Q1 2022 | $845,000 | -2.3% | 8,030 | 0.0% | 0.19% | -3.1% |
| Q4 2021 | $865,000 | -11.4% | 8,030 | -9.9% | 0.20% | -25.9% |
| Q3 2021 | $976,000 | +138.0% | 8,913 | +103.4% | 0.26% | +152.9% |
| Q2 2021 | $410,000 | +1.7% | 4,382 | 0.0% | 0.10% | -8.0% |
| Q1 2021 | $403,000 | -8.4% | 4,382 | -27.2% | 0.11% | -4.2% |
| Q4 2020 | $440,000 | -5.8% | 6,016 | 0.0% | 0.12% | -27.6% |
| Q3 2020 | $467,000 | +74.3% | 6,016 | +24.7% | 0.16% | +52.3% |
| Q2 2020 | $268,000 | +32.7% | 4,826 | -29.2% | 0.11% | -12.3% |
| Q1 2020 | $202,000 | -54.5% | 6,815 | -44.5% | 0.12% | -52.3% |
| Q4 2019 | $444,000 | +32.9% | 12,274 | 0.0% | 0.26% | +26.1% |
| Q3 2019 | $334,000 | – | 12,274 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |